Cutter Capital Management’s Biogen BIIB Stock Holding History

Cutter Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-113,500	Closed	-$15.5M	–	4
2025 Q1	$15.5M	Buy	+113,500	New	+$16.2M	6.76%	3
2024 Q3	–	Sell	-76,726	Closed	-$17.8M	–	30
2024 Q2	$17.8M	Buy	76,726 +24,726	+48%	+$5.37M	5.37%	6
2024 Q1	$11.2M	Buy	+52,000	New	+$12.2M	4.29%	10

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cutter Capital Management's BIIB Position: Q2 2025 in Review

Cutter Capital Management sold out of Biogen (BIIB) in Q2 2025, closing a stake of 113,500 shares — an estimated $15.5M sold.

Cutter Capital Management first reported a position in BIIB in Q1 2024 and held it in 3 quarters. The position peaked at $17.8M in Q2 2024. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

Cutter Capital Management reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
Cutter Capital Management sold 113,500 Biogen shares in Q2 2025, an estimated $15.5M.
Cutter Capital Management first reported a position in Biogen in Q1 2024 and held it in 3 quarters.
Cutter Capital Management's Biogen position peaked at $17.8M in Q2 2024.
866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Cutter Capital Management's 13F filing for Q2 2025.